Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2016 2
2017 1
2018 3
2019 3
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Nanomedicines - Tiny particles and big challenges.
Marques MRC, Choo Q, Ashtikar M, Rocha TC, Bremer-Hoffmann S, Wacker MG. Marques MRC, et al. Among authors: bremer hoffmann s. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:23-43. doi: 10.1016/j.addr.2019.06.003. Epub 2019 Jun 19. Adv Drug Deliv Rev. 2019. PMID: 31226397 Review.
Mapping of the available standards against the regulatory needs for nanomedicines.
Halamoda-Kenzaoui B, Holzwarth U, Roebben G, Bogni A, Bremer-Hoffmann S. Halamoda-Kenzaoui B, et al. Among authors: bremer hoffmann s. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jan;11(1):e1531. doi: 10.1002/wnan.1531. Epub 2018 Jun 20. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 29923692 Free PMC article. Review.
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.
Pistollato F, Bremer-Hoffmann S, Basso G, Cano SS, Elio I, Vergara MM, Giampieri F, Battino M. Pistollato F, et al. Among authors: bremer hoffmann s. Target Oncol. 2016 Feb;11(1):1-16. doi: 10.1007/s11523-015-0378-5. Target Oncol. 2016. PMID: 26275397 Review.
Bridging communities in the field of nanomedicine.
Halamoda-Kenzaoui B, Baconnier S, Bastogne T, Bazile D, Boisseau P, Borchard G, Borgos SE, Calzolai L, Cederbrant K, Di Felice G, Di Francesco T, Dobrovolskaia MA, Gaspar R, Gracia B, Hackley VA, Leyens L, Liptrott N, Park M, Patri A, Roebben G, Roesslein M, Thürmer R, Urbán P, Zuang V, Bremer-Hoffmann S. Halamoda-Kenzaoui B, et al. Among authors: bremer hoffmann s. Regul Toxicol Pharmacol. 2019 Aug;106:187-196. doi: 10.1016/j.yrtph.2019.04.011. Epub 2019 Apr 30. Regul Toxicol Pharmacol. 2019. PMID: 31051191 Free PMC article.
Current status of human pluripotent stem cell based in vitro toxicity tests.
Klaric M, Winkler J, Vojnits K, Meganathan K, Jagtap S, Ensenat-Waser R, Hescheler J, Sachinidis A, Bremer-Hoffmann S. Klaric M, et al. Among authors: bremer hoffmann s. Front Biosci (Schol Ed). 2013 Jan 1;5(1):118-33. doi: 10.2741/s361. Front Biosci (Schol Ed). 2013. PMID: 23277040 Free article. Review.
Future perspectives for advancing regulatory science of nanotechnology-enabled health products.
Halamoda-Kenzaoui B, Geertsma R, Pouw J, Prina-Mello A, Carrer M, Roesslein M, Sips A, Weltring KM, Spring K, Bremer-Hoffmann S. Halamoda-Kenzaoui B, et al. Among authors: bremer hoffmann s. Drug Deliv Transl Res. 2022 Sep;12(9):2145-2156. doi: 10.1007/s13346-022-01165-y. Epub 2022 Jun 12. Drug Deliv Transl Res. 2022. PMID: 35691982 Free PMC article.
14 results